MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
HomeBusinessThe Worst-Performing Medtech IPOs Of 2014 (CareDx)

The Worst-Performing Medtech IPOs Of 2014 (CareDx)

Location: Brisbane, California Products: Molecular diagnostics company focused on tests for heart transplant recipients

molecular diagnostics, CareDx

Location: Brisbane, California

Products: Molecular diagnostics company focused on tests for heart transplant recipients

Date of IPO: July 16

IPO Offer Price: $10 

Deal Size: $40 million

Returns: -30%

    

TAGS: News
Hide comments
account-default-image
user not logged in

More information about text formats

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish
Related
IMEast.png
Medical Design & Manufacturing (MD&M) East 2023
Agreement with a handshake
Scivita Medical Partners with Boston Sci to Broaden Single-use Videoscope Demand
Mar 29, 2023
Calendar pages
This Week Last Year in Medtech: March 19-25
Mar 23, 2023
Financial decrease
Pear Therapeutics Seeks Strategic Alternatives as Purse Strings Tighten
Mar 17, 2023